News Coverage 06.07.22 Share on Twitter Share on Facebook Share on LinkedIn Three-Arm First-Line Chemoimmunotherapy Study in Patients With Metastatic Pancreatic Cancer Related Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Our Impact PICI-Founded Dispatch Bio Takes on Solid Tumors Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker